共 50 条
- [21] 6-Month Versus 12-Month Dual-Antiplatelet Therapy Following Long Everolimus-Eluting Stent Implantation The IVUS-XPL Randomized Clinical TrialJACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (14) : 1438 - 1446Hong, Sung-JinShin, Dong-HoKim, Jung-SunKim, Byeong-KeukKo, Young-GukChoi, DonghoonHer, Ae-YoungKim, Yong HoonJang, YangsooHong, Myeong-Ki
- [22] Is 1-Month Dual Antiplatelet Therapy Applicable to Any Type of Drug-Eluting Stent in Any Clinical Scenario?CIRCULATION JOURNAL, 2024, 88 (06) : 885 - 887Minami, Yoshiyasu
- [23] Efficacy and safety of low-dose clopidogrel after 12-month dual antiplatelet therapy for patients having drug-eluting stent implantationJOURNAL OF THORACIC DISEASE, 2014, 6 (05) : 459 - 465Zhuang, Xiao-DongLong, MingLi, Cui-LingHu, Cheng-HengDu, Zhi-MingLiao, Xin-Xue
- [24] 1-Month Dual-Antiplatelet Therapy Followed by Aspirin Monotherapy After Polymer-Free Drug-Coated Stent Implantation One-Month DAPT TrialJACC-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (16) : 1801 - 1811Hong, Sung-JinKim, Jung-SunHong, Soon JunLim, Do-SunLee, Seung-YulYun, Kyeong HoPark, Jong-KwanKang, Woong CholKim, Yong HoonYoon, Hyuck-JunWon, HoyounNam, Chung-MoAhn, Chul-MinKim, Byeong-KeukKo, Young-GukChoi, DonghoonJang, YangsooHong, Myeong-Ki
- [25] Nine-month clinical outcomes in patients with diabetes treated with polymer-free sirolimus-eluting stents and 6-month vs. 12-month dual-antiplatelet therapy (DAPT)HERZ, 2019, 44 (05) : 433 - 439Krackhardt, F.Waliszewski, M.Rischner, J.Piot, C.Pansieri, M.Ruiz-Povede, F. L.Boxberger, M.Noutsias, M.Rios, X. F.Kherad, B.
- [26] Rationale and design of the Onyx ONE global randomized trial: A randomized controlled trial of high-bleeding risk patients after stent placement with 1 month of dual antiplatelet therapyAMERICAN HEART JOURNAL, 2019, 214 : 134 - 141Kedhi, ElvinLatib, AzeemAbizaid, AlexandreKandzari, DavidKirtane, Ajay J.Mehran, RoxanaPrice, Matthew J.Simon, DanielWorthley, StephenZaman, AzfarBrar, SandeepLiu, MingleiStone, Gregg W.Windecker, Stephan
- [27] Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention The SMART-CHOICE Randomized Clinical TrialJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (24): : 2428 - 2437Hahn, Joo-YongBin Song, YoungOh, Ju-HyeonChun, Woo JungPark, Yong HawnJang, Woo JinIm, Eul-SoonJeong, Jin-OkCho, Byung RyulOh, Seok KyuYun, Kyeong HoCho, Deok-KyuLee, Jong-YoungKoh, Young-YoupBae, Jang-WhanChoi, JaeWoongLee, Wang SooYoon, Hyuck JunLee, Seung UkCho, Jang HyunChoi, Woong GilRha, Seung-WoonLee, Joo MyungPark, Taek KyuYang, Jeong HoonChoi, Jin-HoChoi, Seung-HyuckLee, Sang HoonGwon, Hyeon-CheolKim, Dong-BinCho, Sang CheolHwang, Sun-HoJeon, Dong WoonChoi, Jae WoongRyu, Jae KeanKim, Moo-HyunChae, In-HoKim, Sang-HyunKim, Hack-LyoungCho, Jang HyunJin, Dong KyuSuh, Il WooPark, Jong SeonShin, Eun-SeokKim, Shin-JaeCheong, Sang-SigHo, KyeongLee, Sung YunChae, Jei KeonKoh, Young Youp
- [28] 3-to 6-Month vs 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent Placement: An Updated Meta-AnalysisJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (17) : B284 - B284Singh, SahibGarg, AakashTantry, UdayaBliden, KevinGurbel, Paul
- [30] Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trialEUROINTERVENTION, 2022, 17 (18) : 1467 - +van Geuns, Robert-JanChang Chun-ChinMcEntegart, Margaret B.Merkulov, EvgenyKretov, EvgenyLesiak, MaciejO'Kane, PeterHanratty, Colm G.Bressollette, ErwanSilvestri, MarcWlodarczak, AdrianBarragan, PaulAnderson, RichardProtopopov, AlekseyPeace, AaronMenown, IanRocchiccioli, PaulOnuma, YoshinobuOldroyd, Keith G.